Molecular Mechanism and Blood Flow Imaging of the Formation of Angioarchitech titure during the Occurrence and Progression of Hepatocellular Carcinoma.

肝细胞癌发生发展过程中Angioarchitech结构形成的分子机制及血流成像。

基本信息

  • 批准号:
    10470143
  • 负责人:
  • 金额:
    $ 5.12万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 2000
  • 项目状态:
    已结题

项目摘要

1. Change of Intranodular Blood Flow During the Occurrence and Multistep Progression of Hepatocellular Carcinoma.Hepatocellular carcinoma(HCC)occurs as a hyperplastic nodule at its initiation of cancer. During multistep progression, hyperplastic nodule develops to the early well-differentiated HCC, and finally to advanced moderately differentiated HCC.Consistent with this progression, intranodular hemodynamic also changes, from arterially hypovascular and portally iso-perfusion(type I)to hypoperfusion state both from artery and portal vein(type II). Then it develops to the isovascular(type III)and to the classical hypervascular HCC(type II). This alteration can be detected by in vivo vascular imagings, such as US angiography, CTA, and CTAP.2. Hemodynamic AnalysisIn addition to invasive vascular imaging, contrast harmonic imaging with intravenous injection of ultrasound contrast agent is extremely useful in the detection of intra nodular vascularity, both arterial and portal venous flow.
1.肝细胞癌发生及多阶段发展过程中结节内血流的变化肝细胞癌(HCC)在其癌的起始阶段是一个增生性结节。在多步骤进展过程中,增生结节发展为早期高分化HCC,最后发展为晚期中分化HCC,与此相一致,结节内血流动力学也发生变化,从动脉和门静脉等灌注状态(I型)到动脉和门静脉的低灌注状态(II型)。然后发展为等血管型(III型)和典型的富血管型(II型)。这种改变可以通过体内血管成像检测,如US血管造影、CTA和CTAP。血流动力学分析除了侵入性血管成像,静脉注射超声造影剂的对比谐波成像在检测结节内血管、动脉和门静脉血流方面非常有用。

项目成果

期刊论文数量(210)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kudo M: "Imaging diagnosis of hepatocellular carcinoma." Seminors in Liver Disease. (in press).
工藤 M:“肝细胞癌的影像诊断。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamamoto T, Kudo M, et al.: "Hepatocellular carcinomas intected with the novel TT DNA virus lack viral integration."Biochem Bioph Res Co. 251. 339-343 (1998)
Yamamoto T、Kudo M 等人:“感染新型 TT DNA 病毒的肝细胞癌缺乏病毒整合。”Biochem Bioph Res Co. 251. 339-343 (1998)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tochi H, Kudo M, et al.: "Association between a focal spared area in the fatty liver and intrahepatic efferent blood flow from the gallbladder wall"AJR. 172. 1249-1253 (1999)
Tochi H、Kudo M 等人:“脂肪肝中的局灶性保留区域与胆囊壁的肝内传出血流之间的关联”AJR。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kudo M: "Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions."Seminors in Liver Disease. 19. 297-309 (1999)
Kudo M:“肝细胞癌和癌前/交界性病变的影像诊断。”肝病研讨会。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kudo M: "Riedel's lobe of the liver and its clinical implications."Internal Medicine. 39(2). 87-88 (2000)
Kudo M:“Riedel 肝叶及其临床意义。”内科。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KUDO Masatoshi其他文献

KUDO Masatoshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KUDO Masatoshi', 18)}}的其他基金

Effect of tyrosine kinase inhibitor for immunological microenviroment of hepatocellular carcinoma
酪氨酸激酶抑制剂对肝细胞癌免疫微环境的影响
  • 批准号:
    18K07922
  • 财政年份:
    2018
  • 资助金额:
    $ 5.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of biomarker for sorafenib treatment using serum microRNA in patients with hepatocellular carcinoma
利用血清 microRNA 开发肝细胞癌患者索拉非尼治疗的生物标志物
  • 批准号:
    15K09028
  • 财政年份:
    2015
  • 资助金额:
    $ 5.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Moleculer mechanism of Hepatocarcinogenesis and Development : Combined Analysis with Kupffer phase Contrast-enchanced US and Gene Expression.
肝癌发生和发展的分子机制:库普弗相增强超声和基因表达的联合分析。
  • 批准号:
    23650312
  • 财政年份:
    2010
  • 资助金额:
    $ 5.12万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Newly Developed Image Analysis Method of Tumor Blood Flow : Separate Quantitative Analysis of Intranodular Arterial and Portal Blood Flow and Its Application to Research on Hepatocarcinogenesis
新开发的肿瘤血流图像分析方法:结节内动脉和门静脉血流的单独定量分析及其在肝癌研究中的应用
  • 批准号:
    18300176
  • 财政年份:
    2006
  • 资助金额:
    $ 5.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Hemodynamic and sinusoidal function change during multistep hepatocarcinogenesis : evaluation by contrast harmonic imaging
多步肝癌发生过程中血流动力学和正弦函数的变化:通过对比谐波成像进行评估
  • 批准号:
    16500326
  • 财政年份:
    2004
  • 资助金额:
    $ 5.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Imaging Analysis and Molecular Mechanism of angio architectural Change of the Tumor During Multistep Human Hepatocarcinogenesis
人肝癌多步发生过程中肿瘤血管结构变化的影像学分析及分子机制
  • 批准号:
    14570524
  • 财政年份:
    2002
  • 资助金额:
    $ 5.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

A Bioengineered Model of Tumor Vessel Interactions in Pancreatic Cancer
胰腺癌肿瘤血管相互作用的生物工程模型
  • 批准号:
    10373531
  • 财政年份:
    2022
  • 资助金额:
    $ 5.12万
  • 项目类别:
Development of a Novel Tailored Immunotherapy for Pancreatic Cancer Based on Tumor Vessel Maturation
基于肿瘤血管成熟的新型胰腺癌定制免疫疗法的开发
  • 批准号:
    22K16538
  • 财政年份:
    2022
  • 资助金额:
    $ 5.12万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A Bioengineered Model of Tumor Vessel Interactions in Pancreatic Cancer
胰腺癌肿瘤血管相互作用的生物工程模型
  • 批准号:
    10557226
  • 财政年份:
    2022
  • 资助金额:
    $ 5.12万
  • 项目类别:
Visualization of breast tumor with its tumor vessel and intratumoral hypoxic region by photoacoustic imaging
乳腺肿瘤及其肿瘤血管和瘤内缺氧区域的光声成像可视化
  • 批准号:
    20K16822
  • 财政年份:
    2020
  • 资助金额:
    $ 5.12万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Role of Vascular Endothelial Glutaminase in Tumor Vessel Normalization and Response to Therapy
血管内皮谷氨酰胺酶在肿瘤血管正常化和治疗反应中的作用
  • 批准号:
    10239085
  • 财政年份:
    2019
  • 资助金额:
    $ 5.12万
  • 项目类别:
The role of tumor vessel structures on nanoparticle transport
肿瘤血管结构对纳米颗粒运输的作用
  • 批准号:
    345052
  • 财政年份:
    2016
  • 资助金额:
    $ 5.12万
  • 项目类别:
    Operating Grants
A new strategy in the treatment of pancreatic cancer focused on the tumor vessel remodeling by pericytes
治疗胰腺癌的新策略聚焦于周细胞的肿瘤血管重塑
  • 批准号:
    25462118
  • 财政年份:
    2013
  • 资助金额:
    $ 5.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Downstream of Akt in the tumor vessel
肿瘤血管中 Akt 的下游
  • 批准号:
    8096756
  • 财政年份:
    2008
  • 资助金额:
    $ 5.12万
  • 项目类别:
Downstream of Akt in the tumor vessel
肿瘤血管中 Akt 的下游
  • 批准号:
    7647119
  • 财政年份:
    2008
  • 资助金额:
    $ 5.12万
  • 项目类别:
AKT pathway as a therapeutic tumor vessel target
AKT 通路作为治疗性肿瘤血管靶点
  • 批准号:
    7525417
  • 财政年份:
    2008
  • 资助金额:
    $ 5.12万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了